Lab
Independent Clinical Laboratories LLC
Independent Clinical Laboratories LLC was paid $1.04M by Medicaid between Jan 2018 and Nov 2024, across 30 billing codes. Its largest line is 87798, Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism — 32% of everything it billed.
33Billing provider infoINDEPENDENT CLINICAL LABORATORIES LLC
TAMPA, FL 33619
TAMPA, FL 33619
33aNPI1285707943assigned 11/17/2006
33bProvider typeClinical Medical Laboratory
28Total paid$1.04M
24GClaims92,865
24DCodes billed30
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Florida
Rank by total paid#41 of 225
Median peer was paid$74K
This provider vs. median14×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,426 | $11K | |
| 2019 | 3,145 | $64K | |
| 2020 | 2,111 | $37K | |
| 2021 | 37,588 | $406K | |
| 2022 | 34,639 | $303K | |
| 2023 | 10,647 | $163K | |
| 2024incomplete | 3,309 | $59K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 32% | 8,279 | 6,282 | $332K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 20% | 14,091 | 9,245 | $208K |
| 87481 | 7.9% | 6,411 | 4,888 | $82K | |
| 88312 | 4.3% | 626 | 524 | $44K | |
| 88342 | 4.2% | 1,377 | 969 | $44K | |
| 87529 | 3.1% | 3,277 | 2,569 | $32K | |
| 87641 | 3.1% | 6,815 | 5,178 | $32K | |
| 87500 | 2.9% | 6,720 | 5,096 | $30K | |
| 87653 | 2.8% | 6,123 | 4,693 | $29K | |
| 87631 | 2.6% | 1,589 | 1,149 | $27K | |
| 87640 | 2.3% | 6,774 | 4,927 | $24K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 1.7% | 3,215 | 2,525 | $17K |
18 more codes
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 1.4% | 3,062 | $15K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 1.4% | 2,830 | $15K |
| 87625 | 1.4% | 3,063 | $14K | |
| 87511 | 1.3% | 3,370 | $13K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1.3% | 2,686 | $13K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1.2% | 225 | $13K |
| 87563 | <1% | 3,152 | $9K | |
| 87486 | <1% | 1,567 | $8K | |
| 87581 | <1% | 1,556 | $7K | |
| 87541 | <1% | 1,556 | $7K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 221 | $7K |
| 87556 | <1% | 1,319 | $6K | |
| 87471 | <1% | 815 | $4K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 214 | $3K |
| 87561 | <1% | 806 | $3K | |
| 87493 | <1% | 723 | $3K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 345 | $1K |
| 81514 | 0% | 58 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialNODES, DANIEL (COO)